Artificial contact pathway activation masks the haemostatic potential of rFVIIa and NN1731 in thrombocytopenic whole blood: Correspondence

British Journal of Haematology

Volumn 150, Issue 1, 2010, Pages 124-127

  Larsen, Ole H ^a   Ezban, Mirella ^b   Persson, Egon ^b   Ingerslev, Jørgen ^a   Sørensen, Benny ^a,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Corn trypsin inhibitor; Recombinant factor VIIa; Recombinant factor VIIa analogue; Thrombocytopenia; Thromboelastometry

Indexed keywords

HEMOSTATIC AGENT; NN 1731; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT THROMBOPLASTIN; THROMBOPLASTIN; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG;

BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; DOSE RESPONSE; HEMOSTASIS; HUMAN; IN VITRO STUDY; LETTER; PRIORITY JOURNAL; THROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADULT; BLOOD COAGULATION; DRUG EVALUATION, PRECLINICAL; FACTOR VII; FACTOR VIIA; HEMOSTATICS; HUMANS; RECOMBINANT PROTEINS; THROMBELASTOGRAPHY; THROMBOCYTOPENIA;

EID: 77953526796     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08170.x     Document Type: Letter

References (10)

1. Blajchman, M.A. (2003) Substitutes and alternatives to platelet transfusions in thrombocytopenic patients. Journal of Thrombosis and Haemostasis, 1, 1637 1641.
2. Dargaud, Y., Luddington, R. Baglin, T.P. (2006) Elimination of contact factor activation improves measurement of platelet-dependent thrombin generation by calibrated automated thrombography at low-concentration tissue factor. Journal of Thrombosis and Haemostasis, 4, 1160 1161.
3. Fenger-Eriksen, C., Ingerslev, J., Tonnesen, E. Sørensen, B. (2009) Citrate artificially masks the haemostatic effect of recombinant factor VIIa in dilutional coagulopathy. Annals of Hematology, 88, 255 260.
4. Larsen, O.H., Ingerslev, J. Sørensen, B. (2007) Whole blood laboratory model of thrombocytopenia for use in evaluation of hemostatic interventions. Annals of Hematology, 86, 217 221.
5. Larsen, O.H., Clausen, N., Persson, E., Ezban, M., Ingerslev, J. Sørensen, B. (2009) Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue. British Journal of Haematology, 144, 99 106.
6. Lauritzen, B., Tranholm, M. Ezban, M. (2009) rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats. Journal of Thrombosis and Haemostasis, 7, 651 657.
7. Luddington, R. Baglin, T. (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. Journal of Thrombosis and Haemostasis, 2, 1954 1959.
8. Mann, K.G., Whelihan, M.F., Butenas, S. Orfeo, T. (2007) Citrate anticoagulation and the dynamics of thrombin generation. Journal of Thrombosis and Haemostasis, 5, 2055 2061.
9. Rand, M.D., Lock, J.B., van't Veer, C., Gaffney, D.P. Mann, K.G. (1996) Blood clotting in minimally altered whole blood. Blood, 88, 3432 3445.
10. Sørensen, B., Johansen, P., Christiansen, K., Woelke, M. Ingerslev, J. (2003) Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. Journal of Thrombosis and Haemostasis, 1, 551 558.